Related Experiment Videos
High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy
1Department of Immunohaemotology, Otago Medical School, Dunedin, New Zealand.
Neurology
|March 1, 1989
We treated nine consecutive patients with chronic inflammatory demyelinating polyneuropathy (CIDP) with high-dose intravenous human immunoglobulin (HIG), and clinical recovery rapidly followed. Disability that had persisted for months or years was often reversed in days. There were no major adverse reactions to HIG infusions.
We treated nine consecutive patients with chronic inflammatory demyelinating polyneuropathy (CIDP) with high-dose intravenous human immunoglobulin (HIG), and clinical recovery rapidly followed. Disability that had persisted for months or years was often reversed in days. There were no major adverse reactions to HIG infusions.